封面
市場調查報告書
商品編碼
1736713

2026 年至 2032 年翻新醫療圖像設備市場(按產品類型、應用、最終用戶和地區)

Refurbished Medical Imaging Equipment Market by Product Type, Application, End-User, & Region for 2026-2032

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

翻新醫療圖像設備市場估值-2026 年至 2032 年

翻新醫療圖像設備的價格通常比新設備低40%到60%,因此,它成為一個相當有吸引力的選擇,尤其對於預算有限的醫療機構而言。根據Verified Market Research分析師預測,到2024年,翻新醫療圖像設備市場規模將達到約158.8億美元,預測期內將達到379.4億美元。

由於醫療設備的再製造減少了廢棄物併節約了資源,環保實踐趨勢正在影響市場,這將有助於市場在 2026 年至 2032 年期間以 11.50% 的複合年成長率成長。

翻新醫療圖像設備市場定義/概述

翻新醫療圖像設備是指經過修復,使其安全和性能標準接近原廠設備的醫學影像設備。這些設備經過全面的翻新流程,包括拆卸、清洗、維修、更換磨損零件、軟體更新以及嚴格的品質測試。

與可能以「原樣」出售且不提供保固的二手設備不同,翻新設備享有經銷商或原始製造商的保固支援。此流程確保設備在臨床應用中安全有效,對於希望升級影像處理能力而又無需購買新設備的醫療機構而言,翻新設備是經濟實惠的選擇。

由於其價格實惠和可靠性,對翻新醫療圖像設備的需求不斷增加,尤其是在預算有限的醫療機構中。

慢性病的增加如何影響翻新醫療圖像設備的需求?

慢性病的增加對翻新醫療圖像設備的需求產生了重大影響。根據世界衛生組織 (WHO) 的報告:

據預測,到2050年,全球60歲以上人口將加倍,導致心臟病、糖尿病和關節炎等與老齡化相關的疾病發生率上升。這種人口結構變化將需要增強診斷能力,並促使醫療機構尋求經濟高效的解決方案來獲得先進的影像技術。約70%的醫療服務提供者面臨預算限制,這促使他們考慮將翻新設備作為價格高昂的新設備的可行替代方案。

此外,翻新過程確保這些設備符合安全和性能標準,使醫療保健提供者無需花費大量資本支出即可改善患者照護。因此,對翻新醫療圖像設備的需求是由對可訪問、負擔得起的診斷工具的需求所驅動,以有效管理日益加重的慢性病負擔。

最終用戶的負面看法如何影響翻新醫療圖像設備的採用率?

終端用戶的負面認知會顯著影響翻新醫療圖像設備的採用率。使用者普遍對翻新醫療設備的品質、安全性和可靠性表示擔憂,這使得許多醫療專業人士不願購買。一份報告顯示,約60%的醫院表示,對翻新產品的有效性和耐用性的擔憂是其採用的主要障礙。

此外,對潛在隱患的擔憂以及翻新流程的不確定性也加劇了這種猶豫。目標商標產品製造商 (OEM) 警告醫療機構,他們將不再為舊型號提供支持,這進一步加劇了這些擔憂,阻礙了他們購買翻新設備。因此,翻新流程的透明度以及品質和性能保證對於解決這些擔憂至關重要。如果沒有有效的策略來解決這些問題,翻新醫療圖像設備市場的成長可能會受到阻礙。

目錄

第 1 章全球翻新醫療圖像設備市場簡介

  • 市場概覽
  • 研究範圍
  • 先決條件

第2章執行摘要

第3章:已驗證的市場研究調查方法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源列表

第4章全球翻新醫療圖像設備市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

5. 全球翻新醫療圖像設備市場(按產品)

  • 概述
  • X光設備
  • 超音波診斷設備
  • CT掃描儀
  • 核磁共振造影系統
  • 其他

6. 全球翻新醫療圖像設備市場(按應用)

  • 概述
  • 腫瘤學
  • 循環系統
  • 婦科
  • 整形外科
  • 其他

7. 全球翻新醫療圖像設備市場(依最終用戶)

  • 概述
  • 醫院
  • 診斷影像中心
  • 門診醫療中心
  • 其他

8. 全球翻新醫療圖像設備市場(按地區)

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 其他
    • 拉丁美洲
    • 中東和非洲

第9章 翻新醫療圖像設備的全球競爭格局

  • 概述
  • 各公司市場排名
  • 重點發展策略

第10章 公司簡介

  • GE Healthcare
  • Block Imaging
  • Agito Medical A/S
  • Siemens Healthcare systems
  • Integrity Medical Systems
  • Koninklijke Philips NV
  • Everx Pvt Ltd.
  • JAPAN CENTRAL MEDICAL, INC
  • CURA Healthcare
  • Radiology Oncology Systems, Inc.

第11章 重大進展

  • 產品發布/開發
  • 合併與收購
  • 業務擴展
  • 夥伴關係與合作

第12章 附錄

  • 相關調查
簡介目錄
Product Code: 40275

Refurbished Medical Imaging Equipment Market Valuation - 2026-2032

Refurbished medical imaging equipment is typically available at 40% to 60% less than the price of new devices, making it an attractive option for healthcare facilities, especially those with budget constraints. According to the analyst from Verified Market Research, the refurbished medical imaging equipment market is estimated to reach a valuation of USD 37.94 Billion over the forecast subjugating around USD 15.88 Billion valued in 2024.

The trend towards eco-friendly practices is influencing the market, as refurbishing medical devices reduces waste and conserves resources. It enables the market to grow at a CAGR of 11.50% from 2026 to 2032.

Refurbished Medical Imaging Equipment Market: Definition/Overview

Refurbished medical imaging equipment refers to medical imaging systems that have been restored to meet safety and performance standards comparable to their original condition. These devices undergo a comprehensive refurbishment process, which includes disassembly, cleaning, repair, replacement of worn parts, software updates, and rigorous quality testing.

Unlike used equipment, which may be sold "as is" without guarantees, refurbished devices come with warranties provided by the reseller or the original manufacturer. This process ensures that the equipment is safe and effective for clinical use, making it a cost-effective alternative for healthcare facilities looking to upgrade their imaging capabilities without the expense of new devices.

Refurbished medical imaging equipment is increasingly sought after due to its affordability and reliability, especially in resource-constrained settings where budget considerations are paramount.

How is the Increasing Prevalence of Chronic Diseases Influencing the Demand for Refurbished Medical Imaging Devices?

The increasing prevalence of chronic diseases is significantly influencing the demand for refurbished medical imaging devices. As reported by the World Health Organization (WHO),

the aging population is linked to a rise in chronic conditions, with projections indicating that by 2050, the global population aged 60 years and older will double, resulting in a higher incidence of age-related diseases such as heart disease, diabetes, and arthritis. This demographic shift necessitates enhanced diagnostic capabilities, leading healthcare facilities to seek cost-effective solutions for acquiring advanced imaging technologies. It has been observed that approximately 70% of healthcare providers are facing budget constraints, prompting them to consider refurbished equipment as a viable alternative to new devices, which can be prohibitively expensive.

Furthermore, the refurbishment process ensures that these devices meet safety and performance standards, allowing healthcare providers to enhance patient care without incurring significant capital expenditures. Consequently, the demand for refurbished medical imaging devices is being driven by the need for accessible and affordable diagnostic tools to manage the growing burden of chronic diseases effectively.

In What Ways does the Negative Perception of End-Users Affect the Adoption Rates of Refurbished Medical Imaging Equipment?

The negative perception of end-users significantly affects the adoption rates of refurbished medical imaging equipment. Concerns regarding the quality, safety, and reliability of these devices are commonly expressed, leading many healthcare providers to hesitate in their purchasing decisions. According to a report, approximately 60% of hospitals cite worries about the effectiveness and durability of refurbished equipment as a primary barrier to adoption.

Additionally, fears about potential hidden defects and uncertainties surrounding the refurbishment process contribute to this reluctance. It has been noted that original equipment manufacturers (OEMs) often exacerbate these concerns by warning healthcare facilities that they will not provide support for older models, further discouraging the purchase of refurbished devices. As a result, transparency in the refurbishment process and assurances regarding quality and performance are crucial for addressing these perceptions. Without effective strategies to mitigate these concerns, the growth of the refurbished medical imaging equipment market is likely to be hindered.

Category-Wise Acumens

What Factors Contribute to the High Demand for Refurbished MRI Equipment in the Medical Diagnostics Industry?

The substantial cost savings associated with refurbished MRI systems are being recognized as a primary motivator for healthcare facilities, particularly those operating under budget constraints. It has been reported that new MRI machines can cost millions of dollars, making refurbished options, which are typically available at 40% to 60% less than new models, an attractive alternative for hospitals and clinics seeking to maintain high-quality diagnostic capabilities without incurring excessive capital expenditures.

Additionally, the long service life of MRI equipment allows for effective refurbishment, enabling older systems to be updated with modern software and hardware enhancements, thereby extending their usability and performance. According to the World Health Organization (WHO), the increasing prevalence of chronic diseases necessitates advanced imaging solutions, further fueling demand for affordable and reliable MRI equipment.

What Factors Contribute to the Increasing Demand for Refurbished Medical Imaging Equipment Specifically in Oncology Applications?

The increasing demand for refurbished medical imaging equipment in oncology applications is driven by several critical factors. The rising incidence of cancer globally has been documented, with the World Health Organization (WHO) projecting that cancer cases will reach approximately 29.5 million by 2040, necessitating enhanced diagnostic and treatment capabilities. As healthcare facilities strive to provide effective cancer care, the cost- effectiveness of refurbished imaging equipment becomes a significant consideration, especially given that new imaging systems can be prohibitively expensive. It has been reported that refurbished MRI and CT machines can be obtained at 40% to 60% lower prices than their new counterparts, making them accessible for hospitals with limited budgets.

Additionally, advancements in imaging technology have improved the performance and reliability of refurbished devices, ensuring they meet modern clinical standards for precision in cancer diagnosis and treatment planning. Enhanced imaging techniques, such as image- guided radiotherapy and hybrid imaging systems like PET/CT, are increasingly being integrated into oncology practices, further driving the demand for high-quality refurbished equipment capable of supporting these advanced applications. Consequently, the combination of rising cancer prevalence, cost considerations, and technological advancements significantly contributes to the growing demand for refurbished medical imaging equipment within the oncology segment.

Country/Region-wise Acumens

How does the Increasing Prevalence of Chronic Diseases in North America Drive the Demand for Refurbished Medical Imaging Technologies?

The increasing prevalence of chronic diseases in North America is significantly driving the demand for refurbished medical imaging technologies. According to the U.S. National Center for Health Statistics, an estimated 1,958,310 new cancer cases and 609,820 cancer-related deaths were projected in 2023, highlighting the urgent need for effective diagnostic tools. The rising incidence of chronic conditions such as cancer, cardiovascular diseases, and diabetes

necessitates advanced imaging capabilities for accurate diagnosis and treatment planning. It has been reported that approximately 50% of the U.S. population has a chronic disease, which accounts for 86% of healthcare costs, thereby intensifying the demand for affordable imaging solutions. As healthcare facilities face budget constraints, refurbished medical imaging equipment is increasingly viewed as a cost-effective alternative that provides high- quality diagnostic capabilities without the financial burden associated with new devices.

Additionally, advancements in imaging technology have improved the performance of refurbished systems, ensuring they meet contemporary clinical standards. Consequently, the combination of rising chronic disease prevalence, cost considerations, and technological advancements is substantially contributing to the growing demand for refurbished medical imaging technologies in North America.

What Factors Contribute to the Rapid Economic Growth in the Asia Pacific Region that Supports the Refurbished Medical Imaging Equipment Market?

The rapid economic growth in the Asia Pacific region that supports the refurbished medical imaging equipment market is driven by several key factors. The region is home to approximately 60% of the world's population, creating a substantial demand for healthcare services and advanced medical technologies. According to the Asian Development Bank (ADB), healthcare expenditure in the Asia Pacific is projected to increase significantly, with governments aiming to enhance health systems and achieve universal health coverage (UHC). It has been reported that public health spending in East Asia and the Pacific has been declining since 2011, indicating a pressing need for cost-effective solutions like refurbished medical imaging equipment to maximize limited resources.

Additionally, the increasing prevalence of chronic diseases, alongside a growing aging population, necessitates improved diagnostic capabilities, further driving demand for affordable imaging technologies. Government initiatives promoting public-private partnerships (PPPs) are also being recognized as essential for expanding access to healthcare services and facilitating investments in refurbished equipment. These factors collectively contribute to the robust growth of the refurbished medical imaging equipment market in the Asia Pacific region, as healthcare providers seek to enhance their diagnostic capabilities while managing budget constraints effectively.

Competitive Landscape

The competitive landscape of the refurbished medical imaging equipment market is characterized by a combination of specialized refurbishers, original equipment manufacturers (OEMs) selling certified pre-owned devices, and independent service organizations.

Some of the prominent players operating in the refurbished medical imaging equipment market include:

Siemens Healthineers AG

Canon Medical Systems Corporation

Philips Healthcare

GE Healthcare

DRE Medical

Atlantis Worldwide

Block Imaging

Agito Medical A/S

Soma Technology

EBRO Medical Technologies GmbH

EverX Pty Ltd

Shinmed Corporation

Medivison

Avante Health Solutions

Integrity Medical Systems

Refurbished Medical Equipment

Technomed Services

LA Medical Equipment

Biomedical Imaging Services

Latest Development

In May 2023, Siemens Healthineers AG, in partnership with CommonSpirit Health, acquired Block Imaging, Inc., a leading provider of refurbished medical equipment. This acquisition aims to enhance the repair and reuse of medical equipment, thereby reducing waste and increasing value for customers and patients.

In March 2023, GE Healthcare introduced the GoldSeal Discovery ST, a refurbished imaging system that integrates computed tomography (CT) and Positron Emission Tomography (PET). This system is designed to offer advanced imaging capabilities at a more affordable price, catering to healthcare facilities with budget constraints.

Refurbished Medical Imaging Equipment Market, By Category

  • Product Type:
  • X-ray Devices
  • Ultrasound Systems
  • CT Scanners
  • MRI Equipment
  • Others
  • Application:
  • Oncology
  • Cardiovascular
  • Gynecology
  • Orthopedic
  • Others
  • End-User:
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical Centers
  • Others
  • Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 X-ray Devices
  • 5.3 Ultrasound Systems
  • 5.4 CT Scanners
  • 5.5 MRI Equipment
  • 5.6 Others

6 GLOBAL REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Oncology
  • 6.3 Cardiovascular
  • 6.4 Gynecology
  • 6.5 Orthopedic
  • 6.6 Others

7 GLOBAL REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, END-USER

  • 7.1 Overview
  • 7.2 Hospitals
  • 7.3 Diagnostic Imaging Centers
  • 7.4 Ambulatory Care Centers
  • 7.5 Other

8 GLOBAL REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL REFURBISHED MEDICAL IMAGING EQUIPMENT MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 GE Healthcare
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Block Imaging
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Agito Medical A/S
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Siemens Healthcare systems
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Integrity Medical Systems
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Koninklijke Philips N.V.
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Everx Pvt Ltd.
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 JAPAN CENTRAL MEDICAL, INC
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 CURA Healthcare
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Radiology Oncology Systems, Inc.
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research